These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

175 related items for PubMed ID: 7318845

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Vitamin-D-dependent rickets type II. Resistance of target organs to 1,25-dihydroxyvitamin D.
    Brooks MH, Bell NH, Love L, Stern PH, Orfei E, Queener SF, Hamstra AJ, DeLuca HF.
    N Engl J Med; 1978 May 04; 298(18):996-9. PubMed ID: 205789
    [Abstract] [Full Text] [Related]

  • 3. Evaluation of a role for 1,25-dihydroxyvitamin D3 in the pathogenesis and treatment of X-linked hypophosphatemic rickets and osteomalacia.
    Drezner MK, Lyles KW, Haussler MR, Harrelson JM.
    J Clin Invest; 1980 Nov 04; 66(5):1020-32. PubMed ID: 6253520
    [Abstract] [Full Text] [Related]

  • 4. Vitamin D and vitamin D dependency.
    Tsuchiya Y, Matsuo N, Cho H, Tsubouchi K, Kumagai M, Nishii Y, Nanjoh M, Yamamoto T.
    Contrib Nephrol; 1980 Nov 04; 22():89-100. PubMed ID: 6967387
    [Abstract] [Full Text] [Related]

  • 5. End-organ resistance to 1,25-dihydroxycholecalciferol.
    Liberman UA, Samuel R, Halabe A, Kauli R, Edelstein S, Weisman Y, Papapoulos SE, Clemens TL, Fraher LJ, O'Riordan JL.
    Lancet; 1980 Mar 08; 1(8167):504-6. PubMed ID: 6102232
    [Abstract] [Full Text] [Related]

  • 6. 1,25-dihydroxyvitamin D3 and 1, alpha-hydroxyvitamin D3 in children: biologic and therapeutic effects in nutritional rickets and different types of vitamin D resistance.
    Balsan S, Garabedian M, Sorgniard R, Holick MF, Deluca HF.
    Pediatr Res; 1975 Jul 08; 9(7):586-93. PubMed ID: 169507
    [Abstract] [Full Text] [Related]

  • 7. Rickets of prematurity. Supranormal levels of serum 1,25-dihydroxyvitamin D.
    Chesney RW, Hamstra AJ, DeLuca HF.
    Am J Dis Child; 1981 Jan 08; 135(1):34-7. PubMed ID: 6969986
    [Abstract] [Full Text] [Related]

  • 8. Resistance to vitamin D and parathyroid hormone.
    Moses AM.
    N Engl J Med; 1978 Aug 24; 299(8):423-4. PubMed ID: 209328
    [No Abstract] [Full Text] [Related]

  • 9. An unique form of osteomalacia associated with end organ refractoriness to 1,25-dihydroxyvitamin D and apparent defective synthesis of 25-hydroxyvitamin D.
    Zerwekh JE, Glass K, Jowsey J, Pak CY.
    J Clin Endocrinol Metab; 1979 Aug 24; 49(2):171-5. PubMed ID: 313402
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Vitamin D metabolism and osteomalacia in cystic fibrosis.
    Friedman HZ, Langman CB, Favus MJ.
    Gastroenterology; 1985 Mar 24; 88(3):808-13. PubMed ID: 3871414
    [Abstract] [Full Text] [Related]

  • 13. Supranormal 25-hydroxyvitamin D and subnormal 1,25-dihydroxyvitamin D: their role in X-linked hypophosphatemic rickets.
    Chesney RW, Mazess RB, Rose P, Hamstra AJ, DeLuca HF.
    Am J Dis Child; 1980 Feb 24; 134(2):140-3. PubMed ID: 6243443
    [Abstract] [Full Text] [Related]

  • 14. Elevated serum 1,25 dihydroxyvitamin D concentrations in rickets of very low-birth-weight infants.
    Steichen JJ, Tsang RC, Greer FR, Ho M, Hug G.
    J Pediatr; 1981 Aug 24; 99(2):293-8. PubMed ID: 6265619
    [Abstract] [Full Text] [Related]

  • 15. Vitamin D metabolism in hypophosphatemic rickets.
    Mason RS, Rohl PG, Lissner D, Posen S.
    Am J Dis Child; 1982 Oct 24; 136(10):909-13. PubMed ID: 6981996
    [Abstract] [Full Text] [Related]

  • 16. Role of 1,25-dihydroxyvitamin D3 in maintaining serum phosphorus and curing rickets.
    Tanaka Y, Deluca HF.
    Proc Natl Acad Sci U S A; 1974 Apr 24; 71(4):1040-4. PubMed ID: 4524612
    [Abstract] [Full Text] [Related]

  • 17. Healing of bone disease in X-linked hypophosphatemic rickets/osteomalacia. Induction and maintenance with phosphorus and calcitriol.
    Harrell RM, Lyles KW, Harrelson JM, Friedman NE, Drezner MK.
    J Clin Invest; 1985 Jun 24; 75(6):1858-68. PubMed ID: 3839245
    [Abstract] [Full Text] [Related]

  • 18. 1 alpha-hydroxyvitamin D3 treatment of three patients with 1,25-dihydroxyvitamin D-receptor-defect rickets and alopecia.
    Takeda E, Kuroda Y, Saijo T, Naito E, Kobashi H, Yokota I, Miyao M.
    Pediatrics; 1987 Jul 24; 80(1):97-101. PubMed ID: 3037475
    [Abstract] [Full Text] [Related]

  • 19. Serum 1,25-dihydroxyvitamin D levels in normal subjects and in patients with hereditary rickets or bone disease.
    Scriver CR, Reade TM, DeLuca HF, Hamstra AJ.
    N Engl J Med; 1978 Nov 02; 299(18):976-9. PubMed ID: 308618
    [Abstract] [Full Text] [Related]

  • 20. Vitamin D resistant rickets with alopecia: a form of end organ resistance to 1,25 dihydroxy vitamin D.
    Beer S, Tieder M, Kohelet D, Liberman OA, Vure E, Bar-Joseph G, Gabizon D, Borochowitz ZU, Varon M, Modai D.
    Clin Endocrinol (Oxf); 1981 Apr 02; 14(4):395-402. PubMed ID: 6266702
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.